Archive for APP Pharmaceuticals
You are browsing the archives of APP Pharmaceuticals.
APP launches generic anesthetic injection
APP Pharmaceuticals has launched its rocuronium bromide injection, a generic equivalent of Organon’s anaesthetic Zemuron.
The injection is being sold in two dosages, 50mg and 100mg, and is used mostly in hospitals and clinics as an intravenous neuromuscular blocking agent.
“In addition to safety measures such as barcoding and latex-free stoppers, APP has incorporated a peel-off syringe [...]